misoprostol pregnancy
Selected indexed studies
- ACOG Practice Bulletin No. 200: Early Pregnancy Loss. (Obstet Gynecol, 2018) [PMID:30157093]
- Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. (Int J Gynaecol Obstet, 2007) [PMID:17963768]
- Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. (Int J Gynaecol Obstet, 2007) [PMID:17961566]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. (2006) pubmed
- Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. (2007) pubmed
- ACOG Practice Bulletin No. 200: Early Pregnancy Loss. (2018) pubmed
- Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. (2007) pubmed
- The use of misoprostol in termination of second-trimester pregnancy. (2011) pubmed
- First-trimester cesarean scar pregnancy: a comparative analysis of treatment options from the international registry. (2024) pubmed
- Multi-target mechanism of misoprostol in pregnancy termination based on network pharmacology and molecular docking. (2024) pubmed
- Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. (2010) pubmed
- Misoprostol for the treatment of early pregnancy failure. (2007) pubmed
- Misoprostol and termination of pregnancy: is there a need for ultrasound screening in a general population to assess the risk for adverse outcome in cases of uterine anomaly? (2011) pubmed